SCHEMBL6970367

SCHEMBL6970367

COc1cc(OC)c(C(=O)Nc2nc(C(=O)O)cs2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.55
ACHE P22303 2/20 0.53
ALDH1A1 P00352 4/20 0.52
HSD17B10 Q99714 3/20 0.51
LMNA P02545 2/20 0.51
NPSR1 Q6W5P4 1/20 0.51
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MITF O75030 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
HPGD P15428 1/20 0.49
TSHR P16473 1/20 0.49
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ALPL P05186 1/20 0.46
POLB P06746 1/20 0.46
MAPT P10636 2/20 0.45
HTT P42858 1/20 0.45
MME P08473 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27923650 0.90 ACHE (0.64) L3MBTL1ACHEALDH1A1HSD17B10LMNA
SCHEMBL7055631 0.90 HSD17B10 (0.57) ACHEALDH1A1HSD17B10LMNANPSR1
SCHEMBL6313414 0.84 LMNA (0.72) L3MBTL1ALDH1A1HSD17B10LMNANPSR1
SCHEMBL16789307 0.83 MME (0.61) L3MBTL1ALDH1A1NPC1RAB9AKDM4E
SCHEMBL2764501 0.81 HPGD (0.73) L3MBTL1ALDH1A1HSD17B10LMNANPSR1
SCHEMBL30058880 0.81 ALDH1A1 (0.53) ACHEALDH1A1HSD17B10LMNANPSR1
SCHEMBL6975573 0.80 ACHE (0.67) ACHEALDH1A1HSD17B10LMNANPSR1
SCHEMBL6976220 0.80 LMNA (0.55) ACHEALDH1A1HSD17B10LMNANPSR1
SCHEMBL6975943 0.80 ACHE (0.64) ACHEALDH1A1HSD17B10LMNANPSR1
SCHEMBL6967117 0.80 MAPT (0.71) L3MBTL1ACHEALDH1A1HSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111518052-A Preparation method of acotiamide hydrochloride impurity 廊坊市泽康医药科技有限公司 2020-08-11 CN claimed
CN-105753810-B The refined and preparation method of acotiamide hydrochloride hydrate trihydrate 浙江新赛科药业有限公司 2018-09-28 CN claimed
CN-105753810-A Acotiamide hydrochloride trihydrate refining method and acotiamide hydrochloride trihydrate preparation method 浙江新赛科药业有限公司 2016-07-13 CN claimed
CN-111518052-A Preparation method of acotiamide hydrochloride impurity 廊坊市泽康医药科技有限公司 2020-08-11 CN disclosed
CN-111518052-A Preparation method of acotiamide hydrochloride impurity 廊坊市泽康医药科技有限公司 2020-08-11 CN disclosed
CN-111440128-A Preparation method of acotiamide hydrochloride impurity 廊坊市泽康医药科技有限公司 2020-07-24 CN disclosed
CN-111440128-A Preparation method of acotiamide hydrochloride impurity 廊坊市泽康医药科技有限公司 2020-07-24 CN disclosed
CN-105753810-B The refined and preparation method of acotiamide hydrochloride hydrate trihydrate 浙江新赛科药业有限公司 2018-09-28 CN disclosed
CN-105753810-A Acotiamide hydrochloride trihydrate refining method and acotiamide hydrochloride trihydrate preparation method 浙江新赛科药业有限公司 2016-07-13 CN disclosed
EP-0870765-B1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARM CO LTD (JP) 2003-11-19 EP disclosed
US-5981557-A HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-11-09 US disclosed
EP-0870765-A1 AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS ZERIA PHARMACEUTICAL CO., LTD. (JP) 1998-10-14 EP disclosed